Isma Benattia, Vice President Europe Medical Affairs, Amgen talks about harnessing technology to unlock better outcomes for patients.

Arun Mahtani, Former Vice President, Channels Strategy and Digital Content, Teva Pharmaceuticals, talks about impactful patient initiatives.

Kumaran Krishnan, Director, Medical Excellence and Digital Transformation, Teva, discusses unlocking further potential in developed markets.

Pierre Bourdage, Global Head Biopharmaceuticals, Sandoz, provides insight into the state and future of the biosimilars market.

Patrick Romano, Co-founder and Partner, Eradigm Consulting, talks about his experience as a biochemist, how to build pharmaceutical value propositions fit for the future, and how the industry can navigate the blurring of lines between pharma and public health.

Ian Dorrian, President Communications Europe, Syneos Health, talks about his journey from the pharmaceutical industry to the agency world, what pharma can do to mitigate the spread of fake news, and how long-term use of virtual communication could affect product launches of the future.

Haider Alleg, Global Head of Digital Excellence, Ferring Pharmaceuticals, reveals his fascination with Japanese business methodologies and considers what both the pharmaceutical and financial sectors could stand to learn from one another.

Fran Ayalasomayajula, Head of Population Health Portfolio, Worldwide Healthcare, HP, discusses scaling technological adoption, thought leadership, and the positive impact technology will have on future population health.